Newron Pharmaceuticals S.p.A. (OTCMKTS:NWPHF – Get Free Report) was the target of a significant decline in short interest in April. As of April 30th, there was short interest totaling 78,634 shares, a decline of 51.7% from the April 15th total of 162,794 shares. Approximately 0.4% of the company’s stock are short sold. Based on an […]